Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer
Condition(s):Endometrial CarcinomaLast Updated:November 3, 2023Withdrawn
Hide Studies Not Open or Pending
Condition(s):Endometrial CarcinomaLast Updated:November 3, 2023Withdrawn
Condition(s):Breast CancerLast Updated:March 27, 2018Completed
Condition(s):Ovarian Hyperstimulation SyndromeLast Updated:July 20, 2023Not yet recruiting
Condition(s):Focus of StudyLast Updated:September 26, 2012Completed
Condition(s):Polycystic Ovary SyndromeLast Updated:September 7, 2012Completed
Condition(s):Breast CancerLast Updated:August 22, 2022Completed
Condition(s):Advanced Metastatic Breast CancerLast Updated:October 11, 2021Completed
Condition(s):InfertilityLast Updated:February 7, 2008Completed
Condition(s):Breast NeoplasmsLast Updated:November 30, 2023Completed
Condition(s):Estrogen Receptor-positive Breast Cancer; HER2-negative Breast Cancer; Invasive Ductal Breast Carcinoma; Progesterone Receptor-positive Breast Cancer; Recurrent Breast Cancer; Stage IV Breast CancerLast Updated:December 5, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.